Protagonist Therapeutics INC
+$1.3B
Net Activity
Institutions Holding
316
Popularity Rank
#1885
Avg Weight
0.36%
Total Value
$7.6B
316 institutions currently hold PTGX, with 160 net buyers and 156 net sellers this quarter.
Institutional Moves (Q1 2026)
Neutral
Based on recent trading activity
Net Selling Institutions
156
Net Buying Institutions
160
Top 5 by Value
+$5.3B
Total Buy Value
$1.5B
Total Sell Value
160
Net Buyers
156
Net Sellers
2
Filings (90d)
$1.99M
Total Est. Value
18K shares
Planned Shares
| Filer | Filing Date | Est. Value |
|---|---|---|
| Waddill William D. | 2026-06-23 | $1.04M |
| Waddill William D. | 2026-06-10 | $953K |
Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker。
No Schedule 13D/13G filings for this ticker
No Form 8-K filings for this ticker
The most-added stocks by 13F institutions this quarter
Institutions Holding
6,150
Total reported value
$2.1T
3245 13F institutions increased their position this quarter
Institutions Holding
5,957
Total reported value
$1.5T
3028 13F institutions increased their position this quarter
Institutions Holding
5,764
Total reported value
$3.0T
2743 13F institutions increased their position this quarter